(BSJS) Invesco BulletShares 2028 - Ratings and Ratios
High-Yield Bonds, Corporate Debt, Fixed Income, 2028 Maturity, Sampling
Dividends
| Dividend Yield | 6.47% |
| Yield on Cost 5y | 7.56% |
| Yield CAGR 5y | 3.78% |
| Payout Consistency | 90.3% |
| Payout Ratio | - |
| Risk via 5d forecast | |
|---|---|
| Volatility | 2.17% |
| Value at Risk 5%th | 3.54% |
| Relative Tail Risk | -0.72% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.62 |
| Alpha | 0.86 |
| CAGR/Max DD | 1.57 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.367 |
| Beta | 0.211 |
| Beta Downside | 0.182 |
| Drawdowns 3y | |
|---|---|
| Max DD | 5.00% |
| Mean DD | 0.77% |
| Median DD | 0.35% |
Description: BSJS Invesco BulletShares 2028 December 28, 2025
The Invesco BulletShares 2028 High Yield Corporate Bond ETF (BSJS) aims to track an index of U.S. dollar-denominated high-yield (junk) corporate bonds that mature around 2028. The fund commits at least 80% of its assets to securities in that index but employs a sampling approach rather than buying every constituent, seeking to replicate the index’s return profile while managing transaction costs and liquidity constraints.
Key market metrics to watch include: (1) the fund’s weighted-average yield, which currently sits near 7.2% annualized, reflecting the higher compensation investors demand for credit risk; (2) its effective duration of roughly 3.5 years, indicating moderate sensitivity to changes in the federal funds rate; and (3) the high-yield spread over Treasuries, which has widened to about 350 basis points, signaling heightened credit concerns amid a tightening monetary environment. Sector exposure is heavily weighted toward energy and industrials, both of which are sensitive to commodity price cycles and global supply-chain dynamics.
For a deeper, data-driven look at BSJS’s risk-adjusted performance and scenario analysis, the ValueRay platform offers a useful, interactive toolkit.
What is the price of BSJS shares?
Over the past week, the price has changed by +0.27%, over one month by +0.90%, over three months by +1.85% and over the past year by +8.01%.
Is BSJS a buy, sell or hold?
What are the forecasts/targets for the BSJS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 24.7 | 12% |
BSJS Fundamental Data Overview January 07, 2026
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 569.1m USD (569.1m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 569.1m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 569.1m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 6.69% (E(569.1m)/V(569.1m) * Re(6.69%) + (debt-free company))
Discount Rate = 6.69% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Fair Price DCF = unknown (Cash Flow 0.0)
Additional Sources for BSJS ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle